Descovy and Memory loss - a phase IV clinical study of FDA data

Summary:

Memory loss is reported as a side effect among people who take Descovy (emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Tivicay, and have Back pain.

The phase IV clinical study analyzes which people have Memory loss when taking Descovy. It is created by eHealthMe based on reports of 14,206 people who have side effects when taking Descovy from the FDA, and is updated regularly.

What is Descovy?

Descovy has active ingredients of emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 14,260 Descovy users. Check the latest studies of Descovy.

What is Memory loss?

Memory loss is found to be associated with 2,728 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.

On Jul, 18, 2026

14,206 people reported to have side effects when taking Descovy.
Among them, 32 people (0.23%) have Memory loss.

Among these 32 people:

How long have people been on Descovy when they have Memory loss? *

What is the gender of people who have Memory loss when taking Descovy? *

female: 36.67 %
male: 63.33 %

What is the age of people who have Memory loss when taking Descovy? *

What are other drugs people take besides Descovy? *

What are other side effects people have besides Memory loss? *

Speech Impairment (Adult) (inability to speak (adult)): 6 people, 18.75%
Weight Decreased: 6 people, 18.75%
Diabetes: 5 people, 15.62%
Emotional Distress: 5 people, 15.62%
Speech Disorder: 5 people, 15.62%
Clavicle Fracture: 5 people, 15.62%
Stress And Anxiety: 5 people, 15.62%
Renal Impairment (severely reduced kidney function): 5 people, 15.62%
Fatigue (feeling of tiredness): 5 people, 15.62%
Blood Glucose Increased: 5 people, 15.62%

What are the existing conditions these people have? *

Pain: 4 people, 12.50%
Back Pain: 4 people, 12.50%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 3 people, 9.38%
Stress And Anxiety: 2 people, 6.25%
Nausea And Vomiting: 2 people, 6.25%
Urinary Tract Disorder: 2 people, 6.25%
High Blood Pressure: 2 people, 6.25%
Dyspnea (difficult or laboured breathing): 1 person, 3.12%
Allergic Rhinitis: 1 person, 3.12%
Appetite Disorder (abnormal eating habits): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Descovy and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Descovy:

Descovy (14,260 reports)

Memory loss treatments and more:

Memory loss (244,444 reports)

How severe was Memory loss and when was it recovered:

Memory loss in Descovy

Expand to all the drugs that have ingredients of emtricitabine; tenofovir alafenamide fumarate:

Memory loss and drugs with ingredients of emtricitabine; tenofovir alafenamide fumarate (35 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Descovy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Memory loss:

Memory loss (2,728 drugs)

Browse all the conditions that are associated with Memory loss:

Memory loss (4,375 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Descovy) and Descovy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.